1. Home
  2. VOYA vs CYTK Comparison

VOYA vs CYTK Comparison

Compare VOYA & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voya Financial Inc.

VOYA

Voya Financial Inc.

HOLD

Current Price

$75.93

Market Cap

6.7B

Sector

Finance

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$61.73

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VOYA
CYTK
Founded
1975
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
8.0B
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
VOYA
CYTK
Price
$75.93
$61.73
Analyst Decision
Buy
Strong Buy
Analyst Count
11
16
Target Price
$83.64
$82.38
AVG Volume (30 Days)
753.6K
2.1M
Earning Date
02-03-2026
11-05-2025
Dividend Yield
2.49%
N/A
EPS Growth
N/A
N/A
EPS
5.82
N/A
Revenue
$8,088,000,000.00
$87,211,000.00
Revenue This Year
N/A
$346.43
Revenue Next Year
$5.02
$57.69
P/E Ratio
$12.98
N/A
Revenue Growth
2.91
2609.26
52 Week Low
$52.43
$29.31
52 Week High
$78.00
$70.98

Technical Indicators

Market Signals
Indicator
VOYA
CYTK
Relative Strength Index (RSI) 61.97 47.26
Support Level $74.26 $60.42
Resistance Level $76.34 $64.43
Average True Range (ATR) 1.30 2.77
MACD 0.05 -0.13
Stochastic Oscillator 81.11 20.93

Price Performance

Historical Comparison
VOYA
CYTK

About VOYA Voya Financial Inc.

Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: